ArticleMolecular cancer2017

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.

Candani S A Tutuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.